Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

822 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
ERα-mediated cell cycle progression is an important requisite for CDK4/6 inhibitor response in HR+ breast cancer.
Petrossian K, Kanaya N, Lo C, Hsu PY, Nguyen D, Yang L, Yang L, Warden C, Wu X, Pillai R, Bernal L, Huang CS, Kruper L, Yuan Y, Somlo G, Mortimer J, Chen S. Petrossian K, et al. Among authors: pillai r. Oncotarget. 2018 Jun 12;9(45):27736-27751. doi: 10.18632/oncotarget.25552. eCollection 2018 Jun 12. Oncotarget. 2018. PMID: 29963233 Free PMC article.
Association between Clonal Hematopoiesis and Late Nonrelapse Mortality after Autologous Hematopoietic Cell Transplantation.
Slavin TP, Teh JB, Weitzel JN, Peng K, Wong FL, Qin H, Wang J, Wu X, Mei M, Pillai R, Wang Y, Tsang KK, Pozhitkov A, Krishnan A, Forman SJ, Armenian SH. Slavin TP, et al. Among authors: pillai r. Biol Blood Marrow Transplant. 2019 Dec;25(12):2517-2521. doi: 10.1016/j.bbmt.2019.08.013. Epub 2019 Aug 22. Biol Blood Marrow Transplant. 2019. PMID: 31445185 Free PMC article.
Double-hit Signature with TP53 Abnormalities Predicts Poor Survival in Patients with Germinal Center Type Diffuse Large B-cell Lymphoma Treated with R-CHOP.
Song JY, Perry AM, Herrera AF, Chen L, Skrabek P, Nasr MR, Ottesen RA, Nikowitz J, Bedell V, Murata-Collins J, Li Y, McCarthy C, Pillai R, Wang J, Wu X, Zain J, Popplewell L, Kwak LW, Nademanee AP, Niland JC, Scott DW, Gong Q, Chan WC, Weisenburger DD. Song JY, et al. Among authors: pillai r. Clin Cancer Res. 2021 Mar 15;27(6):1671-1680. doi: 10.1158/1078-0432.CCR-20-2378. Epub 2021 Jan 7. Clin Cancer Res. 2021. PMID: 33414134 Free PMC article.
Late and very late relapsed acute lymphoblastic leukemia: clinical and molecular features, and treatment outcomes.
Aldoss I, Pillai R, Yang D, Yang L, Arslan S, Mokhtari S, Malki MMA, Salhotra A, Shahani S, Ali H, Mei M, Artz A, Snyder D, Afkhami M, Armenian S, Stein A, Marcucci G, Forman SJ, Nakamura R, Pullarkat V. Aldoss I, et al. Among authors: pillai r. Blood Cancer J. 2021 Jul 2;11(7):125. doi: 10.1038/s41408-021-00516-1. Blood Cancer J. 2021. PMID: 34215723 Free PMC article. No abstract available.
Mutation and immune profiling of metaplastic breast cancer: Correlation with survival.
Afkhami M, Schmolze D, Yost SE, Frankel PH, Dagis A, Amanam IU, Telatar M, Nguyen K, Yu KW, Luu T, Pillai R, Aoun PA, Mortimer J, Yuan Y. Afkhami M, et al. Among authors: pillai r. PLoS One. 2019 Nov 6;14(11):e0224726. doi: 10.1371/journal.pone.0224726. eCollection 2019. PLoS One. 2019. PMID: 31693690 Free PMC article.
Clinical and Molecular Features of KRAS-Mutated Lung Cancer Patients Treated with Immune Checkpoint Inhibitors.
Zhao D, Li H, Mambetsariev I, Mirzapoiazova T, Chen C, Fricke J, Kulkarni P, Villaflor V, Arvanitis L, Hamilton S, Afkhami M, Pillai R, Armstrong B, Erhunmwunsee L, Massarelli E, Sattler M, Amini A, Salgia R. Zhao D, et al. Among authors: pillai r. Cancers (Basel). 2022 Oct 8;14(19):4933. doi: 10.3390/cancers14194933. Cancers (Basel). 2022. PMID: 36230855 Free PMC article.
822 results